Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|July 30, 2022
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancerJustin A Chen, Jasmine C Huynh, Chun-Yi Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2024
Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)David Kozono, Xing Hua, Michael C Wu, et al.
Clinical Lung Cancer|October 13, 2004
Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trialPrimo N Lara, Paul H Gumerlock, Philip C Mack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2018
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer PatientsOliver A Zill, Kimberly C Banks, Stephen R Fairclough, et al.
Frontiers in Oncology|March 6, 2024
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkersDouglas I Lin, Richard S P Huang, Ioannis Ladas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibitionPrimo N Lara, David I Quinn, Kim Margolin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomicsDavid R Gandara, Tomoya Kawaguchi, John Crowley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 14, 2021
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for InvestigationChristian Rolfo, Noy Meshulami, Alessandro Russo, et al.
The Lancet. Oncology|July 23, 2013
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trialDavid I Quinn, Catherine M Tangen, Maha Hussain, et al.
Pageof 13